Neridronic acid vs infliximab in patients with ankylosing spondylitis
Phase of Trial: Phase II
Latest Information Update: 24 Sep 2013
Price : $35 *
At a glance
- Drugs Neridronic acid (Primary) ; Infliximab
- Indications Ankylosing spondylitis
- Focus Therapeutic Use
- 24 Sep 2013 Results published in Rheumatology.
- 23 Jun 2013 New trial record
- 15 Jun 2013 Results presented at the 14th Annual Congress of the European League Against Rheumatism.